These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21723443)

  • 1. Racial influence on the polycystic ovary syndrome phenotype: a black and white case-control study.
    Ladson G; Dodson WC; Sweet SD; Archibong AE; Kunselman AR; Demers LM; Williams NI; Coney P; Legro RS
    Fertil Steril; 2011 Jul; 96(1):224-229.e2. PubMed ID: 21723443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Black women with polycystic ovary syndrome (PCOS) have increased risk for metabolic syndrome and cardiovascular disease compared with white women with PCOS [corrected].
    Hillman JK; Johnson LN; Limaye M; Feldman RA; Sammel M; Dokras A
    Fertil Steril; 2014 Feb; 101(2):530-5. PubMed ID: 24382375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS).
    Kumar A; Woods KS; Bartolucci AA; Azziz R
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):644-9. PubMed ID: 15943823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher high-density lipoprotein cholesterol in African-American women with polycystic ovary syndrome compared with Caucasian counterparts.
    Koval KW; Setji TL; Reyes E; Brown AJ
    J Clin Endocrinol Metab; 2010 Sep; 95(9):E49-53. PubMed ID: 20534766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in cardio metabolic risk between Black and White women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Kazemi M; Kim JY; Parry SA; Azziz R; Lujan ME
    Am J Obstet Gynecol; 2021 May; 224(5):428-444.e8. PubMed ID: 33316275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between polycystic ovary syndrome and ancestry in European Americans.
    Bjonnes AC; Saxena R; Welt CK
    Fertil Steril; 2016 Dec; 106(7):1772-1777. PubMed ID: 27666562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome.
    Guedikian AA; Lee AY; Grogan TR; Abbott DH; Largaespada K; Chazenbalk GD; Dumesic DA
    Fertil Steril; 2018 Mar; 109(3):508-515. PubMed ID: 29428312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations.
    Welt CK; Arason G; Gudmundsson JA; Adams J; Palsdóttir H; Gudlaugsdóttir G; Ingadóttir G; Crowley WF
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4361-8. PubMed ID: 16940441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperandrogenism Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women.
    Dumesic DA; Akopians AL; Madrigal VK; Ramirez E; Margolis DJ; Sarma MK; Thomas AM; Grogan TR; Haykal R; Schooler TA; Okeya BL; Abbott DH; Chazenbalk GD
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4178-4188. PubMed ID: 27571186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Han Chinese polycystic ovary syndrome risk variants in women of European ancestry: relationship to FSH levels and glucose tolerance.
    Saxena R; Georgopoulos NA; Braaten TJ; Bjonnes AC; Koika V; Panidis D; Welt CK
    Hum Reprod; 2015 Jun; 30(6):1454-9. PubMed ID: 25904635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACC/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome.
    Marchesan LB; Spritzer PM
    Fertil Steril; 2019 Mar; 111(3):579-587.e1. PubMed ID: 30827526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in dietary intake between women with polycystic ovary syndrome and healthy controls.
    Douglas CC; Norris LE; Oster RA; Darnell BE; Azziz R; Gower BA
    Fertil Steril; 2006 Aug; 86(2):411-7. PubMed ID: 16762348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
    Ezeh U; Pall M; Mathur R; Azziz R
    Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome.
    Glueck CJ; Papanna R; Wang P; Goldenberg N; Sieve-Smith L
    Metabolism; 2003 Jul; 52(7):908-15. PubMed ID: 12870169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density and body composition in lean women with polycystic ovary syndrome.
    Good C; Tulchinsky M; Mauger D; Demers LM; Legro RS
    Fertil Steril; 1999 Jul; 72(1):21-5. PubMed ID: 10428143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperinsulinemia and circulating dehydroepiandrosterone sulfate in white and Mexican American women with polycystic ovary syndrome.
    Kauffman RP; Baker VM; DiMarino P; Castracane VD
    Fertil Steril; 2006 Apr; 85(4):1010-6. PubMed ID: 16580388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
    Barber TM; Casanueva FF; Karpe F; Lage M; Franks S; McCarthy MI; Wass JA
    Eur J Endocrinol; 2008 Apr; 158(4):511-6. PubMed ID: 18362298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis.
    Wekker V; van Dammen L; Koning A; Heida KY; Painter RC; Limpens J; Laven JSE; Roeters van Lennep JE; Roseboom TJ; Hoek A
    Hum Reprod Update; 2020 Nov; 26(6):942-960. PubMed ID: 32995872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
    Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
    Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.